Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    06-December-2000      
Issue 237 Next Update - 14:00 UTC 08:00 EST    07-December-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Proceed To Article In Today's Vidyya
anxiety cover
Talc and wood dust carinogenic? Probably.

Proceed To Article Wood Dust, Talc, Estrogens, And Nickel Alloys Among Substances Being Reviewed For Inclusion In Report On Carcinogens
Wood dust produced in furniture and cabinet manufacture, and common talc are among the substances being considered for listing in the next federal Report on Carcinogens. To assist the National Toxicology Program in preparing the report, a group of scientific advisers will review the proposed substances Dec. 13-15 at the Wyndham City Center, 1143 New Hampshire Ave. NW, Washington, D.C. The meeting is open to the public. More...

Proceed To Article New Breast Cancer Monitoring Test Receives FDA Clearance
Bayer Diagnostics announced today the US Food and Drug Administration (FDA) clearance of its 510(k) application for the Bayer HER-2/neu serum test for use in the follow-up and monitoring of patients with metastatic breast cancer. The Bayer serum HER-2/neu test is the first FDA-cleared blood test for measuring circulating levels of the HER-2/neu oncoprotein. More...

Proceed To Article Colorectal Cancer Traced To Smoking
In the largest prospective study of cigarette smoking and colorectal cancer mortality, American Cancer Society staff researchers report finding strong evidence for classifying cancers of the colon and rectum as, in part, smoking-related. More...

Proceed To Article US FDA Panel Recommends New Therapy Option For Select Group Of Atrial Fibrillation Patients
An advisory panel to the US Food and Drug Administration (FDA) today took a first step to facilitate use by US cardiologists of emerging therapeutic options to help many Americans suffering from atrial fibrillation, the world's most common heart rhythm disorder. The panel, made up of physicians, other scientists and consumer members, voted to recommend that the FDA approve expansion of indications for the use of the Medtronic Jewel® AF implantable cardioverter defibrillator, which was approved by the agency for US commercial release in June 2000. More...

Proceed To Article

AMA Statement On Access To Emergency Contraception
Yesterday, the AMA approved recommendations regarding greater access to emergency contraception pills (ECPs). Two brand names for emergency contraceptive pills are Preven and Plan B. More...

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.